Clinical Performance of the Roche SARS-CoV-2 Serologic Assay
Detection Principle
ImmunoAssay-Antibody
Target
nucleocapside protein
Testing Method Category
Other Immuno assay
Testing Method
Roche Elecsys Anti-SARS-CoV-2 assay compared to two serologic assays [Abbott and EUROIMMUN (EI)]
Testing Method - Additional Info
Comparison performance of Roche Elecsys, Abbot and Euroimmun serologic assay to PCR assay
Reported Performance
Specificity compared to PCR: Roche 98.69%; Abbot 99.34%; EI: 94.77%. Sensitivity >14d post symptoms: Roche 89.36%; Abbott: 93.76%; EI: 85.42%.
Sample Size
153 negative, 102 positive samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements